Terilogy Holdings Corporation (TYO:5133)
301.00
-4.00 (-1.31%)
Sep 3, 2026, 3:30 PM JST
Terilogy Holdings Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 10,932 | 10,646 | 8,653 | 6,881 | 5,676 | 3,195 | |
Revenue Growth | 20.96% | 23.03% | 25.75% | 21.23% | 77.63% | -19.10% |
Cost of Revenue | 7,446 | 7,235 | 5,836 | 4,588 | 3,683 | 2,046 |
Gross Profit | 3,486 | 3,411 | 2,817 | 2,293 | 1,993 | 1,149 |
Selling, General & Admin | 3,027 | 2,862 | 2,544 | 2,020 | 1,878 | - |
Other Operating Expenses | - | - | - | - | - | 865.39 |
Operating Expenses | 3,030 | 2,865 | 2,544 | 2,020 | 1,878 | 912.9 |
Operating Income | 456 | 546 | 273 | 273 | 115 | 236.21 |
Interest Expense | -4 | -2 | -2 | -2 | - | -9.86 |
Interest & Investment Income | 3 | 3 | - | - | - | - |
Earnings From Equity Investments | 2 | 9 | 3 | - | - | - |
Currency Exchange Gain (Loss) | 126 | 44 | 91 | 83 | 5 | - |
Other Non Operating Income (Expenses) | 27 | 13 | 10 | 12 | 7 | 90.53 |
EBT Excluding Unusual Items | 610 | 613 | 375 | 366 | 127 | 316.89 |
Gain (Loss) on Sale of Investments | -3 | -3 | - | -44 | - | - |
Asset Writedown | 34 | 37 | -50 | 29 | -11 | - |
Other Unusual Items | -1 | -1 | -7 | - | - | - |
Pretax Income | 640 | 646 | 318 | 351 | 116 | 316.89 |
Income Tax Expense | 262 | 275 | 134 | 157 | 57 | 76.57 |
Earnings From Continuing Operations | 378 | 371 | 184 | 194 | 59 | 240.32 |
Net Income to Company | - | 371 | 184 | 194 | 59 | - |
Minority Interest in Earnings | -26 | -25 | -8 | -6 | -13 | - |
Net Income | 352 | 346 | 176 | 188 | 46 | 240.32 |
Net Income to Common | 352 | 346 | 176 | 188 | 46 | 240.32 |
Net Income Growth | 70.87% | 96.59% | -6.38% | 308.70% | -80.86% | -43.91% |
Shares Outstanding (Basic) | 17 | 17 | 17 | 16 | 17 | - |
Shares Outstanding (Diluted) | 17 | 17 | 17 | 16 | 17 | - |
Shares Change | 0.84% | 1.90% | 2.82% | -4.24% | - | - |
EPS (Basic) | 20.58 | 20.23 | 10.48 | 11.49 | 2.77 | - |
EPS (Diluted) | 20.55 | 20.20 | 10.44 | 11.49 | 2.77 | - |
EPS Growth | 69.94% | 93.49% | -9.15% | 314.40% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | 1,484 | -143 | 205 | 217 | - |
Free Cash Flow Per Share | - | 86.39 | -8.48 | 12.50 | 12.68 | - |
Dividend Per Share | 5.200 | 5.200 | 5.000 | 5.000 | 5.000 | - |
Dividend Growth | 4.00% | 4.00% | 0% | 0% | - | - |
Gross Margin | 31.89% | 32.04% | 32.55% | 33.32% | 35.11% | 35.96% |
Operating Margin | 4.17% | 5.13% | 3.16% | 3.97% | 2.03% | 7.39% |
Profit Margin | 3.22% | 3.25% | 2.03% | 2.73% | 0.81% | 7.52% |
Free Cash Flow Margin | - | 13.94% | -1.65% | 2.98% | 3.82% | - |
EBITDA | 710.75 | 795 | 499 | 454 | 294 | 283.71 |
EBITDA Margin | 6.50% | 7.47% | 5.77% | 6.60% | 5.18% | 8.88% |
D&A For EBITDA | 254.75 | 249 | 226 | 181 | 179 | - |
EBIT | 456 | 546 | 273 | 273 | 115 | 236.21 |
EBIT Margin | 4.17% | 5.13% | 3.16% | 3.97% | 2.03% | 7.39% |
Effective Tax Rate | 40.94% | 42.57% | 42.14% | 44.73% | 49.14% | - |